Article Cited by others


Glucocorticoids and prostate cancer treatment: friend or foe?

Montgomery Bruce, Cheng Heather H, Drechsler James, Mostaghel Elahe A

Year : 2014| Volume: 16| Issue : 3 | Page no: 354-358

   This article has been cited by
1 Strength training protects against prostate injury in alcoholic rats
Giovana Rampazzo Teixeira,Luiz Gustavo Almeida Chuffa,Leonardo Oliveira Mendes,Allice Santos Cruz Veras,James McCabe,Wagner José Favaro,Patricia Fernanda Felipe Pinheiro,Joăo Paulo Arruda Amorim,Otávio Augusto Martins,Wilson Mello-Junior,Francisco Eduardo Martinez
Journal of Cellular Physiology. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Adverse Events Associated with Cumulative Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis
Neil M. Schultz,David F. Penson,Samuel Wilson,Yan Song,Hongbo Yang,Krishnan Ramaswamy,Benjamin Lowentritt
Drug Safety. 2019;
[Pubmed]  [Google Scholar] [DOI]
3 ETS Proteins Bind with Glucocorticoid Receptors: Relevance for Treatment of Ewing Sarcoma
Swati Srivastava,Nishanth Belugali Nataraj,Arunachalam Sekar,Soma Ghosh,Chamutal Bornstein,Diana Drago-Garcia,Lee Roth,Donatella Romaniello,Ilaria Marrocco,Eyal David,Yuval Gilad,Mattia Lauriola,Ron Rotkopf,Adi Kimchi,Yuya Haga,Yasuo Tsutsumi,Olivier Mirabeau,Didier Surdez,Andrei Zinovyev,Olivier Delattre,Heinrich Kovar,Ido Amit,Yosef Yarden
Cell Reports. 2019; 29(1): 104
[Pubmed]  [Google Scholar] [DOI]
4 Conceptual review of key themes in treating prostate cancer in older adults
Ramy Sedhom,Arjun Gupta
Journal of Geriatric Oncology. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells
Leanne Woods-Burnham,Christina K. Cajigas-Du Ross,Arthur Love,Anamika Basu,Evelyn S. Sanchez-Hernandez,Shannalee R. Martinez,Greisha L. Ortiz-Hernández,Laura Stiel,Alfonso M. Durán,Colwick Wilson,Susanne Montgomery,Sourav Roy,Carlos A. Casiano
Scientific Reports. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]
6 Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer
Zhu Wang,Dinglan Wu,Chi-Fai Ng,Jeremy Yuen-Chun Teoh,Shan Yu,Yuliang Wang,Franky L Chan
Endocrine-Related Cancer. 2018; 25(1): 35
[Pubmed]  [Google Scholar] [DOI]
7 Molecular and cellular mechanisms of castration resistant prostate cancer (Review)
Yiqiao Huang,Xianhan Jiang,Xue Liang,Ganggang Jiang
Oncology Letters. 2018;
[Pubmed]  [Google Scholar] [DOI]
8 Mometasone furoate inhibits growth of acute leukemia cells in childhood by regulating PI3K signaling pathway
Xiaojing Wang,Jianli Shi,Deqiang Gong
Hematology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
9 Molecular underpinnings of enzalutamide resistance
S Prekovic,T Van den Broeck,S Linder,M E van Royen,A B Houtsmuller,F Handle,S Joniau,W Zwart,F Claessens
Endocrine-Related Cancer. 2018; 25(11): R545
[Pubmed]  [Google Scholar] [DOI]
10 Emerging aspects of microRNA interaction with TMPRSS2-ERG and endocrine therapy
Eugenio Zoni,Sofia Karkampouna,George N. Thalmann,Marianna Kruithof-de Julio,Martin Spahn
Molecular and Cellular Endocrinology. 2017;
[Pubmed]  [Google Scholar] [DOI]
11 Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer
Jianneng Li,Mohammad Alyamani,Ao Zhang,Kai-Hsiung Chang,Michael Berk,Zhenfei Li,Ziqi Zhu,Marianne Petro,Cristina Magi-Galluzzi,Mary-Ellen Taplin,Jorge A Garcia,Kevin Courtney,Eric A Klein,Nima Sharifi
eLife. 2017; 6
[Pubmed]  [Google Scholar] [DOI]
12 Glucocorticoid receptor antagonism reverts docetaxel resistance in human prostate cancer
Jan Kroon,Martin Puhr,Jeroen T Buijs,Geertje van der Horst,Daniëlle M Hemmer,Koen A Marijt,Ming S Hwang,Motasim Masood,Stefan Grimm,Gert Storm,Josbert M Metselaar,Onno C Meijer,Zoran Culig,Gabri van der Pluijm
Endocrine-Related Cancer. 2016; 23(1): 35
[Pubmed]  [Google Scholar] [DOI]
13 Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm
Lynn Jongen,Robert Paridaens,Giuseppe Floris,Hans Wildiers,Patrick Neven
Breast Cancer Research and Treatment. 2016;
[Pubmed]  [Google Scholar] [DOI]
14 Managing Metastatic Castration-Resistant Prostate Cancer in the Pre-chemotherapy Setting: A Changing Approach in the Era of New Targeted Agents
Zafeiris Zafeiriou,Anuradha Jayaram,Adam Sharp,Johann S. de Bono
Drugs. 2016;
[Pubmed]  [Google Scholar] [DOI]
15 The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside
Jieping Hu,Qingke Chen
International Urology and Nephrology. 2016;
[Pubmed]  [Google Scholar] [DOI]
16 Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer
Jan Kroon,Sander Kooijman,Nam-Joon Cho,Gert Storm,Gabri van der Pluijm
Trends in Pharmacological Sciences. 2016;
[Pubmed]  [Google Scholar] [DOI]
17 WOMEN IN CANCER THEMATIC REVIEW: New roles for nuclear receptors in prostate cancer
Damien A Leach,Sue M Powell,Charlotte L Bevan
Endocrine-Related Cancer. 2016; 23(11): T85
[Pubmed]  [Google Scholar] [DOI]
18 Androgen–glucocorticoid interactions in the era of novel prostate cancer therapy
Sujata Narayanan,Sandy Srinivas,David Feldman
Nature Reviews Urology. 2015; 13(1): 47
[Pubmed]  [Google Scholar] [DOI]
19 Anticancer Activity of a Novel Selective CYP17A1 Inhibitor in Preclinical Models of Castrate-Resistant Prostate Cancer
Paul J. Toren,Soojin Kim,Steven Pham,Azzra Mangalji,Hans Adomat,Emma S. Tomlinson Guns,Amina Zoubeidi,William Moore,Martin E. Gleave
Molecular Cancer Therapeutics. 2015; 14(1): 59
[Pubmed]  [Google Scholar] [DOI]
20 Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects
R Ferraldeschi,J Welti,J Luo,G Attard,J S de Bono
Oncogene. 2015; 34(14): 1745
[Pubmed]  [Google Scholar] [DOI]
21 The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors
Ning Xie,Helen Cheng,Dong Lin,Liangliang Liu,Ou Yang,Li Jia,Ladan Fazli,Martin E. Gleave,Yuzhuo Wang,Paul Rennie,Xuesen Dong
International Journal of Cancer. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]


Read this article